newsfilter
← Latest News
GlobeNewswire·

Zogenix Launches Global Access Program for FINTEPLA® (Fenfluramine) Oral Solution

FINTEPLA is approved in the U.S. and European Union as an add-on therapy for the treatment of seizures associated with Dravet syndrome in patients aged two years and older. The new program supports physician access to FINTEPLA in other parts of the wor